0 items USD 0.00Search
- Did you mean
- bruton’s tyrolit kinase
Your search for "Bruton's tyrosine kinase" gave back 19245 results.
IGF1R Antibody is a specific antibody used to detect and study IGF1R protein (Insulin-like Growth Factor 1 Receptor). The global IGF1R Antibody...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
FGFR5 Antibody is a specific antibody used to detect and study FGFR5 protein (Fibroblast Growth Factor Receptor 5). The global FGFR5 Antibody market...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
EGFR tyrosine kinase inhibitors (TKIs) are molecules that could inhibt EGFR function through binding. Its monotherapy as first-line treatment can...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
FGFR3, also known as CD333, Is a member of the fibroblast growth factor receptor (FGFR) family, with its amino acid sequence being highly conserved...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
EGFR tyrosine kinase inhibitors (TKIs) are molecules that could inhibt EGFR function through binding. Its monotherapy as first-line treatment can...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Lapatinib (INN), used in the form of lapatinib ditosylate, (USAN) (Tykerb/Tyverb, GSK) is an orally active drug for breast cancer and other solid...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Exeter erlotinib hydrochloride tablets are medications indicated for cancer diseases. The global Exeter Erlotinib Hydrochloride Tablet market was...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Tyrosine Protein Phosphatase Non Receptor Type 1 market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global HER2 Target Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023...
Catalog:
GIR
November 2023
Price: USD 4,480.00
The most effective targeted drug introduced for HCC has been sorafenib. Sorafenib, a multi-tyrosine kinase inhibitor (TKI), remains the only systemic...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The most effective targeted drug introduced for HCC has been sorafenib. Sorafenib, a multi-tyrosine kinase inhibitor (TKI), remains the only systemic...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
EGFR tyrosine kinase inhibitors (TKIs) are molecules that could inhibt EGFR function through binding. Its monotherapy as first-line treatment can...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Rho associated coiled-coil containing protein kinase 2 is a protein that in humans is encoded by the ROCK2 gene. The protein encoded by this gene is...
Catalog:
MRRPB5
November 2023
Price: USD 4,350.00
The global Lapatinib Ditosylate API market size was valued at USD 14 million in 2023 and is forecast to a readjusted size of USD 19 million by 2030...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Phosphoinositide 3-Kinase Inhibitor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
